Entries updated in the last month, starting from most recent update to least recent one.
The latest updates may not be immediately available here
through the BMRB database search.
| Entry ID | Release Date | Title |
|---|---|---|
| 53675 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 52613 | 2026-07-01 | Promiscuous and multivalent interactions between Eps15 and partner protein Dab2 generate a complex interaction network |
| 53650 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53651 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53652 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53653 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53654 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53655 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53656 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53657 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53658 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53659 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53660 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53661 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53662 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53664 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53665 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53666 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53667 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53668 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53669 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53670 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53671 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53672 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53673 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53674 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 52863 | 2026-07-01 | Promiscuous and multivalent interactions between Eps15 and partner protein Dab2 generate a complex interaction network |
| 52864 | 2026-07-01 | Promiscuous and multivalent interactions between Eps15 and partner protein Dab2 generate a complex interaction network |
| 52866 | 2026-07-01 | Promiscuous and multivalent interactions between Eps15 and partner protein Dab2 generate a complex interaction network |
| 52867 | 2026-07-01 | Promiscuous and multivalent interactions between Eps15 and partner protein Dab2 generate a complex interaction network |
| 53636 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53637 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53638 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53639 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53640 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53641 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53642 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53643 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53644 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53645 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53646 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53647 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53648 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53649 | 2026-07-01 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 52872 | 2026-06-26 | A structural basis for chaperone repression of stress signaling from the endoplasmic reticulum |
| 52878 | 2026-06-26 | Solution mapping of MHC-I:TCR interactions using a minimalistic protein system |
| 52879 | 2026-06-26 | Solution mapping of MHC-I:TCR interactions using a minimalistic protein system |
| 52895 | 2026-06-26 | Resonance assignment of the intrinsically disordered actin-binding region of Drebrin |
| 52880 | 2026-06-26 | Solution mapping of MHC-I:TCR interactions using a minimalistic protein system |
| 52869 | 2026-06-26 | 1H, 13C and 15N chemical shift assignments of Rubella virus macro domain in the free and in the ADPr bound state |
| 52870 | 2026-06-26 | 1H, 13C and 15N chemical shift assignments of Rubella virus macro domain in the free and in the ADPr bound state |
| 52894 | 2026-06-26 | Structure and activity of conopressins: insights into in silico oxytocin/V2 receptor interactions, anti-inflammatory potential, and behavioural studies |
| 52973 | 2026-06-16 | Towards a unified molecular mechanism for ligand-dependent activation of NR4A-RXR heterodimers |
| 52961 | 2026-06-16 | Structural and functional dissection of the WH2/DAD motif of INF2, a formin linked to human inherited degenerative disorders |
| 51895 | 2026-06-16 | The clinical missense variant E282K in PPP3CA/calcineurin shifts substrate dephosphorylation by altering active site recruitment |
| 53386 | 2026-06-12 | 1H, 13C, 15N backbone chemical shift assignments and relaxation analysis of the single and tandem RRMs of the human serine-arginine rich splicing factor 6 (SRSF6) |
| 52801 | 2026-06-12 | 1H, 13C, 15N backbone chemical shift assignments and relaxation analysis of the single and tandem RRMs of the human serine-arginine rich splicing factor 6 (SRSF6) |
| 53412 | 2026-06-12 | 1H, 13C, 15N backbone chemical shift assignments and relaxation analysis of the single and tandem RRMs of the human serine-arginine rich splicing factor 6 (SRSF6) |
| 53126 | 2026-06-12 | 1H, 13C, 15N backbone chemical shift assignments and relaxation analysis of the single and tandem RRMs of the human serine-arginine rich splicing factor 6 (SRSF6) |
| 53484 | 2026-06-11 | Intermolecular beta-sheet Formation Guides the Interaction between Ubiquitin-like Modifier FAT10 and Adapter Protein NUB1L |
| 53485 | 2026-06-11 | Intermolecular beta-sheet Formation Guides the Interaction between Ubiquitin-like Modifier FAT10 and Adapter Protein NUB1L |
| 52959 | 2026-06-10 | Conformational analysis of biomineral proteins with intrinsically disordered regions interacting with solid calcium carbonate using dispersive calcium carbonate particles for solution NMR |
| 52960 | 2026-06-10 | Conformational analysis of biomineral proteins with intrinsically disordered regions interacting with solid calcium carbonate using dispersive calcium carbonate particles for solution NMR |
| 52696 | 2026-06-05 | Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments |
| 52695 | 2026-06-05 | Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments |
| 52694 | 2026-06-05 | Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments |
| 53230 | 2026-06-05 | Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments |
| 52697 | 2026-06-05 | Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments |